Drug Information Update- New FDA Drug Info: Drug Safety Podcasts

The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.

FDA's Division of Drug Information has posted new Drug Safety Podcasts for Healthcare Professionals. Click on the following links to read transcripts and listen to podcasts.

• FDA evaluating the potential risks of using codeine cough-and-cold medicines in children
• FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes 
• FDA warns about a serious lung condition in infants and newborns treated with Proglycem (diazoxide)
• FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for magnetic resonance imaging (MRI)

You can download other Drug Safety Podcasts at: FDA Drug Safety Podcasts or subscribe to the Drug Safety Podcasts channel in iTunes at: Drug Safety Podcasts.

---

This is an automated message delivery system.  Replying to this message will not reach DDI staff.  If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm ET Monday - Friday.  You can also email us at druginfo@fda.hhs.gov.

• For additional drug information, please visit the DDI Web page.
• For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info.
• This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA).